Uncategorized

Strategy, appointments, major clinical, medical and regulatory advances, and partnerships: you can find all the latest Ipsen Group press releases here.

February 9, 2023

Ipsen delivers FY and Q4 2022 results – A word from CEO David Loew

News | Uncategorized News Article

December 20, 2022

Living with PBC: The Person Behind the Chart

News | Uncategorized News Article

October 31, 2019

Ipsen in Oncology: Unlocking the power of data

News | Uncategorized News Article

October 4, 2018

Jefferies London Healthcare Conference – November 14, 2018

Uncategorized News Article

March 19, 2018

LivingWithNETs.com awarded as Most valuable patient initiative by Eyeforpharma Awards 2018*

News | Uncategorized News Article

March 19, 2018

Ipsen Named One of the Best Workplaces in Ireland

News | Uncategorized News Article

March 15, 2018

Exelixis Submits U.S. Supplemental New Drug Application for CABOMETYX® (Cabozantinib) for Previously Treated Advanced Hepatocellular Carcinoma

News | Uncategorized News Article

February 15, 2018

International Childhood Cancer Day, Ipsen mobilizes its teams

News | Uncategorized News Article

February 14, 2018

Ipsen’s Full Year 2017 Financial Results

News | Uncategorized News Article

January 15, 2018

Ipsen at ASCO GI 2018

News | Uncategorized News Article

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023